San Francisco Paralegal Association
  • Home
  • News
  • Gilead is accused of cutting anti-competitive deals to extend profit on HIV drug ‘cocktails’

Gilead is accused of cutting anti-competitive deals to extend profit on HIV drug ‘cocktails’

05/14/2019 4:49 PM | Denise Bashline (Administrator)

Washington Post

May 14, 2019


Among the partners named along with Gilead as defendants were Bristol-Myers Squibb and Janssen, a division of Johnson & Johnson. 


https://www.washingtonpost.com/business/economy/gilead-is-accused-of-cutting-anti-competitive-deals-to-extend-profit-on-hiv-drug-cocktails/2019/05/14/94e79c56-75ad-11e9-bd25-c989555e7766_story.html?utm_term=.07c7102b1084




San Francisco Paralegal Association • 1 Sansome St., Ste. 3500 • San Francisco, CA 94104-4448 • (415) 946-8935 • info@sfpa.com